LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 58.21 | 771.67 | 1149 | 8085 | 0.1421 | 0.1246 | MN20160304_L01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 60.44 | 771.67 | 1011 | 8530 | 0.1185 | 0.0810 | MN20160304_L01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 60.44 | 771.67 | 1120 | 8530 | 0.1313 | 0.1135 | MN20160304_L01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 62.66 | 771.67 | 999 | 8978 | 0.1113 | 0.0757 | MN20160304_L01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 62.66 | 771.67 | 1108 | 8978 | 0.1234 | 0.1076 | MN20160304_L01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 64.88 | 771.67 | 979 | 9447 | 0.1036 | 0.0681 | MN20160304_L01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 64.88 | 771.67 | 1096 | 9447 | 0.1160 | 0.1020 | MN20160304_L01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 67.10 | 771.67 | 976 | 9800 | 0.0996 | 0.0662 | MN20160304_L01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 67.10 | 771.67 | 1071 | 9800 | 0.1093 | 0.0935 | MN20160304_L01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 69.32 | 771.67 | 972 | 10212 | 0.0952 | 0.0639 | MN20160304_L01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 69.32 | 771.67 | 1053 | 10212 | 0.1031 | 0.0870 | MN20160304_L01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 71.54 | 771.67 | 946 | 10532 | 0.0898 | 0.0555 | MN20160304_L01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 71.54 | 771.67 | 1036 | 10532 | 0.0984 | 0.0813 | MN20160304_L01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 73.76 | 771.67 | 928 | 10851 | 0.0855 | 0.0496 | MN20160304_L01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 73.76 | 771.67 | 997 | 10851 | 0.0919 | 0.0695 | MN20160304_L01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 76.02 | 771.67 | 905 | 11106 | 0.0815 | 0.0423 | MN20160304_L01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 76.02 | 771.67 | 996 | 11106 | 0.0897 | 0.0686 | MN20160304_L01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 78.25 | 771.67 | 888 | 11367 | 0.0781 | 0.0368 | MN20160304_L01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 78.25 | 771.67 | 953 | 11367 | 0.0838 | 0.0559 | MN20160304_L01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 80.48 | 771.67 | 890 | 11685 | 0.0762 | 0.0371 | MN20160304_L01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 80.48 | 771.67 | 919 | 11685 | 0.0786 | 0.0456 | MN20160304_L01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 82.69 | 771.67 | 884 | 11974 | 0.0738 | 0.0350 | MN20160304_L01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 82.69 | 771.67 | 863 | 11974 | 0.0721 | 0.0287 | MN20160304_L01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 84.92 | 771.67 | 859 | 12266 | 0.0700 | 0.0272 | MN20160304_L01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 84.92 | 771.67 | 842 | 12266 | 0.0686 | 0.0221 | MN20160304_L01 | K20 |